Skip to main content
. 2019 May 22;115(14):1975–1985. doi: 10.1093/cvr/cvz136

Figure 4.

Figure 4

Effects of cilnidipine on AF substrate and conduction properties after 3-week AF. Intergroup differences in AF-vulnerability (A), AF-duration (B), RAA ERP (C), LAA ERP (D), and conduction velocity (E). Cilnidipine significantly attenuated AF-induced changes in AF vulnerability, atrial ERP, and conduction velocity (n = 8 dogs/group for A–D; 6 for E). *P < 0.05, **P < 0.01, ***P < 0.001 vs. Sham, by one-way ANOVA with Tukey’s test. #P < 0.05, ##P < 0.01 vs. AF + cilnidipine, by one-way ANOVA with Tukey’s test.